10x Genomics, Inc. ( TXG) - Key Metrics
TXG Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $1.16 | -$0.14 | $0.13 | $0.12 |
| 2026Q1 | $1.18 | -$0.10 | $0.20 | $0.19 |
| 2025Q4 | $1.31 | -$0.13 | $0.32 | $0.31 |
| 2025Q3 | $1.19 | -$0.22 | $0.34 | $0.34 |
| 2025Q2 | $1.40 | $0.28 | $0.14 | $0.13 |
TXG Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -68.46 |
| 2026Q1 | 0% | -53.07 |
| 2025Q4 | 0% | -31.37 |
| 2025Q3 | 0% | -13.28 |
| 2025Q2 | 0% | 10.34 |
TXG Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.31% | 0% |
| 2026Q1 | 0.90% | 0% |
| 2025Q4 | 1.88% | 0% |
| 2025Q3 | 2.90% | 0% |
| 2025Q2 | 1.13% | 0% |
TXG
Price: $68.59
52 week price:
Earnings Per Share: -0.59 USD
Exchange: NMS
Sector: Healthcare
Industry: Health Information Services
Country: United States
Volume: 10738
Market Capitalization: 7.9 billion